CytoLynx Therapeutics
Shanghai
About CytoLynx Therapeutics
CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $45.0M
- Last round: Undisclosed (Sep 2021)
- Website: cytoviatx.comcytolynx-therapeutics
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/cytolynx-therapeutics-70455 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.